Unity Biotechnology (UBX) Financials

$0.07

$-0.09 (-56.25%)

As on 08-Aug-2025 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	0.24	4.78	--
Cost of Revenue	-0.89	--	19.70	2.18	2.88	3.45
Gross Profit	0.89	--	-19.70	-1.94	1.90	-3.45
Operating Expenses	30.19	31.17	24.97	57.81	61.45	91.33
Operating Profit (EBIT)	-29.96	-31.17	-44.67	-57.57	-56.67	-93.93
Other Income	--	--	--	-0.22	--	0.18
Profit before Tax	-27.50	-25.99	-39.86	-59.93	-60.73	-93.84
Provision for Tax	-0.58	--	6.20	-2.18	-0.69	-1.98
Profit after Tax (Net Income)	-27.50	-25.99	-39.86	-57.75	-60.04	-91.87
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-59.93	-60.73	-93.84

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-0.21	6.49	28.40	66.85	59.57	82.88
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	21.49	21.91	29.45	37.88	48.53	58.98
Current Liabilities	9.07	9.26	7.84	19.62	16.62	14.46
Total Liabilities	39.41	37.66	65.69	124.35	124.71	156.32

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	12.70	13.40	19.09	27.82	34.21	55.45
Current Assets	17.65	24.27	46.61	96.54	90.50	100.87
Total Assets	39.41	37.66	65.69	124.35	124.71	156.32
Total Debt*	18.68	23.54	26.99	47.36	51.56	58.98
Net Current Assets	8.58	15.01	38.77	76.92	73.89	86.40

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-20.87	-38.65	-51.03	-45.06	-78.33
Cash Flow from Investing Activities	--	8.57	60.50	-24.55	39.31	-5.21
Cash from Financing Activities	--	0.08	-16.34	54.86	20.85	63.88
Net Cash Inflow / Outflow	--	--	--	-20.72	--	-19.67

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-60.85	-47.01	-51.25	-47.46	-69.97
ROE (%)	--	-148.97	-83.70	-91.36	-84.30	-90.25
ROA (%)	-51.89	-50.29	-41.95	-46.37	-42.73	-59.74
EBIT Margin (%)	--	--	--	-17,335.17	-1,202.93	--
Net Margin (%)	--	--	--	-481,225.00	-1,255.00	-50,477.47
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	-1.00	-0.95	--	--
EBIT Growth (%)	17.15	18.96	5.98	28.91	37.82	-0.26
Net Profit Growth (%)	20.93	34.80	30.97	3.82	34.65	-22.70
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	2.59	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.23	-0.01	0.43	1.22	0.67	0.43
Close Price ($)	1.04	0.98	1.93	2.74	14.60	52.40
High Price ($)	3.10	2.02	5.72	19.11	97.80	154.40
Low Price ($)	0.94	0.94	1.46	2.09	12.30	27.20
Market Cap ($ Cr)	3.44	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	3.62	0.95	0.71	0.87	0.71
Short term debt to equity ratio	-18.68	--	0.12	0.19	0.12	0.05
Current Ratio	1.95	2.62	5.94	4.92	5.45	6.97
Quick Ratio	1.95	--	--	4.93	--	--
Interest Coverage	--	--	-15.69	-11.50	-18.11	-71.63

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	99.58	--	--
Asset Turnover	--	--	--	0.00	0.03	--
Receivable days	--	--	--	363.70	--	--
Inventory Days	--	--	-4.36	-39.37	--	--
Payable days	--	--	29.39	316.24	288.08	409.99
Cash Conversion Cycle	--	--	--	8.09	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.